Clinical Trial Update: A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a radiation sensitizer added to radiochemotherapy for thoracic esophageal cancer, sponsored by Shandong Luye Pharmaceutical Co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Radiation sensitizer (unspecified)

Snippet

Sponsor: Shandong Luye Pharmaceutical Co., Ltd. | Conditions: Esophageal Carcinoma | Phase 4 | Status: UNKNOWN